Taxol plus gemcitabine and vinorelbine given every other week in advanced chemo-naïve non-small cell lung cancer patients

Oncology

Volumn 65, Issue 4, 2003, Pages 378-379

  Frasci, Giuseppe ^a   Comella, Pasquale ^b   De Cataldis, Giuseppe ^b   Maiorino, Luigi ^b   Fiore, Francesco ^b   De Rosa, Vincenzo ^b   Lapenta, Liliana ^b   Licenziato, Marina ^b   Comella, Giuseppe ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; NAVELBINE; PACLITAXEL;

ANEMIA; ANOREXIA; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; FATIGUE; FEBRILE NEUTROPENIA; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MOTOR NEUROPATHY; NEUROTOXICITY; NEUTROPENIA; PARESTHESIA; PERIPHERAL NEUROPATHY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SENSORY NEUROPATHY; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; ITALY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL; TREATMENT OUTCOME; VINBLASTINE;

EID: 0346689069     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074652     Document Type: Letter

References (8)

1. Gralla R: New directions in non-small cell lung cancer. Semin Oncol 1990;17(4 suppl 7):20-29.
2. Non-small Cell Lung Cancer Cooperative Group: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patient data from 52 randomised clinical trials. BMJ 1995;311:899-909.
3. Comella P, Frasci G, Panza N, et al: Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: A phase II randomized study of the Southern Italy Cooperative Oncology Group. J Clin Oncol 1999;17:1526-1534.
4. Frasci G, Panza N, Comella P, et al: Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small cell lung cancer: A phase I-II study. J Clin Oncol 1999;17:2316-2325.
5. Lorusso V, Carpagnano F, Frasci G, et al: Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer. J Clin Oncol 2000;18:405-411.
6. De Pas T, de Braud F, Danesi R, et al: Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naive patients with advanced non-small-cell lung cancer. Ann Oncol 2000;11:821-827.
7. Isla D, Rosell R, Sanchez JJ, et al: Phase II trial of paclitaxel plus gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 2001;19:1071-1077.
8. Gridelli C, Frontini L, Perrone F, et al: Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: A phase II study of three different doses. Br J Cancer 2000;83:707-714.